CIPA is thought to result from loss-of-function mutation defects in TRKA, which encodes the neurotrophic tyrosine kinase receptor type 1 (NTRK1 or TRKA), a high-affinity receptor for nerve growth factor (NGF) [2]. The gene discussed is NGF; the disease is hereditary sensory and autonomic neuropathy type 4.